Skip to main content
Yoon Hong Choi on Muck Rack

Yoon Hong Choi

As seen in: PLOS Medicine, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yoon Hong

Contact Yoon Hong, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Identifying drivers of pertussis disease resurgence pilot study: Final report

|
By Patricia Campbell, Yoon Hong Choi, Manoj Gambhir, Jodie McVernon
| medRxiv
The authors have declared no competing interest. This study was funded by the World Health Organization. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (14) Issue with article?

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study

|
By Nick Andrews, Yoon Hong Choi
| PLOS Medicine Verified
Loading metrics Open Access Peer-reviewed Research Article Yoon Hong Choi , Nick Andrews, Elizabeth Miller Yoon Hong Choi, Nick Andrews, Elizabeth Miller Published: July 3, 2019 https://doi.org/10.1371/journal.pmed.1002845 Figures Abstract Background In October 2017, the United Kingdom Joint Committee on Vaccination and Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal conjugate vaccine (PCV13) from the existing 2+1 schedule (2, 4, 12 months).
Open in Who Shared Issue with article?
See all 2 articles